Hedeker Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hedeker Wealth's BMY Position: Q2 2021 in Review
Hedeker Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 36,313 shares — an estimated $2.29M sold.
Hedeker Wealth first reported a position in BMY in Q3 2015 and held it in 23 quarters. The position peaked at $3.3M in Q1 2020. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Hedeker Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Hedeker Wealth sold 36,313 Bristol-Myers Squibb shares in Q2 2021, an estimated $2.29M.
- Hedeker Wealth first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 23 quarters.
- Hedeker Wealth's Bristol-Myers Squibb position peaked at $3.3M in Q1 2020.
- 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Hedeker Wealth's 13F filing for Q2 2021, filed 21 Jul 2021.